Fig. 5: MD simulations of possible VLZ binding poses. | Nature Communications

Fig. 5: MD simulations of possible VLZ binding poses.

From: The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter

Fig. 5: MD simulations of possible VLZ binding poses.

Zoomed view of VLZ modeled into the allosteric binding site of SERT. Parts of SERT TMs and bound IMI are removed for clarity. a The refined cryo-EM SERT structure (blue ribbons) with VLZ (magenta) superimposed onto the final MD simulated SERT structure (orange ribbons) with VLZ (orange) in the hypothezised pose. b Structure of the refined SERT:VLZ complex modeled with the 180° flipped VLZ in its binding site and superimposed onto the final MD simulated SERT structure (gray ribbons) with VLZ (gray) in the flipped pose. The MD simulations-derived structures of (c) SERT with VLZ bound at the hypothesized pose and (d) the flipped pose, both superimposed on the VLZ electron density from the cryo-EM structure. e, f As in c and d, viewed from the plane of the membrane, showing that the indole ring in the hypothesized pose could explain the density feature in the cryo-EM structure. TM: Transmembrane.

Back to article page